Tiziana Life Sciences CEO Ivor Elrifi buys USD 667,000 in shares
TLSA•CEO buys 667,000 common shares
Tiziana Life Sciences CEO Ivor Elrifi bought 667,000 common shares on Nasdaq at USD 1 per share.
The purchase lifted his total holding to 4,472,261 common shares.




